It is well documented that the IKKβ–NF-κB signaling pathway not only induces the transcription of proinflammatory mediators, such as IL-1β, IL-6, TNF-α, but also contributes to IR and NAFLD development [52]. Here, IL1B is linked to metabolic dysfunction-associated steatotic liver disease.